Impact of Structured Exercise Programs on Cognitive, Motor and Behavioral Outcomes in Children With ADHD
NCT07376863, Not applicable, Completed, Cukurova University
Trial 10
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
| Field | Value | Source |
|---|---|---|
| Title | Impact of Structured Exercise Programs on Cognitive, Motor and Behavioral Outcomes in Children With ADHD | ClinicalTrials.gov |
| NCT number | NCT07376863 | ClinicalTrials.gov |
| Status | Completed | ClinicalTrials.gov |
| Phases | Not applicable | ClinicalTrials.gov |
| Enrollment | 51 participants, actual | ClinicalTrials.gov |
| Lead sponsor | Cukurova University | ClinicalTrials.gov |
| Conditions | Attention Deficit Hyperactivity Disorder (ADHD) | ClinicalTrials.gov |
| Interventions | Gince Zumba Exercise, Square Stepping Exercise | ClinicalTrials.gov |
| First posted | 2026-01-29 | ClinicalTrials.gov |
| Last updated | 2026-01-29 | ClinicalTrials.gov |
Registered outcomes 6
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description | Source |
|---|---|---|---|---|
| Primary | Stroop Color Test Completion Time | Baseline and at the end of the 8-week intervention | The Stroop Color Test is a neuropsychological assessment used to evaluate selective attention, cognitive flexibility, and inhibitory control. In this study, the primary outcome is the total time required to complete the interference condition of the Stroop task, measured in seconds. Shorter completion time indicates better attentional control and executive functioning. Measurements will be obtained before and after the 8-week exercise intervention. | ClinicalTrials.gov |
| Primary | Visual-Auditory Digit Span Test Total Score | Baseline and after 8 weeks | The Visual-Auditory Digit Span Test (VADST) is a neuropsychological assessment used to evaluate short-term memory and working memory through auditory and visual digit recall tasks. The primary outcome measure is the total test score, expressed in points, obtained from correct responses across all subtests. Higher total scores indicate better memory performance and cognitive processing capacity. The assessment will be administered at baseline and after the 8-week intervention period. | ClinicalTrials.gov |
| Secondary | Blaze Pod Reaction Time Score | Baseline and after 8 weeks | The BlazePod system is a light-based interactive training and assessment tool used to evaluate visuomotor performance. The secondary outcome measure is the mean reaction time, recorded in milliseconds, representing the time elapsed between the visual stimulus and the participant's motor response. Shorter reaction time indicates faster visuomotor processing and motor response speed. Reaction time data will be collected digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. | ClinicalTrials.gov |
| Secondary | Blaze Pod Number of Hits | Baseline and after 8 weeks | The BlazePod system is a light-based interactive assessment tool used to evaluate visuomotor performance and response accuracy. The secondary outcome measure is the total number of correct responses (hits) recorded during the task. Hits represent the number of targets successfully activated within the predefined assessment duration. Higher hit counts indicate better visuomotor coordination and task performance. Performance data will be recorded digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. | ClinicalTrials.gov |
| Secondary | Blaze Pod Total Number of Errors | Baseline and after 8 weeks | The BlazePod system is a light-based interactive assessment tool used to evaluate visuomotor performance during goal-directed motor tasks. The secondary outcome measure is the total error score, calculated as the sum of missed targets (miss hits) and incorrect responses (strikes) recorded during the assessment. The total error score is expressed as a numerical count. Lower error scores indicate better response accuracy and motor control. All performance data will be recorded digitally via the BlazePod mobile application. The assessment will be conducted at baseline and after the 8-week intervention period. | ClinicalTrials.gov |
| Secondary | Conners Parent Rating Scale Total Score | Baseline and after 8 weeks | The Conners Parent Rating Scale (CPRS) is a standardized questionnaire used to assess behavioral symptoms associated with attention-deficit/hyperactivity disorder (ADHD) in children, as reported by parents. The secondary outcome measure is the total score obtained from the scale, expressed in points based on parent responses to Likert-type items. Higher total scores indicate greater severity of ADHD-related behavioral symptoms. The assessment will be completed by parents at baseline and after the 8-week intervention period. | ClinicalTrials.gov |
Outcomes 0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
| Type | Outcome | Time frame | Population | Units | Measured as | Source |
|---|
Results by group 0
Each measurement the trial posted, group by group, in the words and numbers it posted.
| Outcome | Group | Category | Value | Spread | Units | Source |
|---|
Participant flow 0
How many started, completed or left each group, period by period.
| Period | Milestone | Group | Participants | Units counted | Source |
|---|
Adverse events 0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
| Type | Event | Organ system | Group | Affected | At risk | Events | Source |
|---|
Adverse event totals 0
The totals the trial posted for each group.
| Total | Group | Affected | At risk | Source |
|---|
Papers 0
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as | Source |
|---|
Grants 0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years | Source |
|---|
Trial comparisons 0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
| Comparison | Source |
|---|
Tests 2
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
| Test | Named as | Source |
|---|---|---|
| Digit Span Test | Primary outcome | ConductCognition |
| Stroop Color-Word Test | Primary outcome | ConductCognition |
Source 5
| Field | Value | Source |
|---|---|---|
| Release | trials-2026-11-12-0.4.0 | ClinicalTrials.gov |
| Release manifest SHA-256 | 0f4a8d8c48aee2a7573ae0fa94ecbeab70c1adbe449bbc95c424bc7d3e97b9d4 | ClinicalTrials.gov |
| Registry capture | 2026-11-12 | ClinicalTrials.gov |
| Results copy, AACT | 2026-03-23 | ClinicalTrials.gov |
| NIH clinical studies file | 2026-11-13 | ClinicalTrials.gov |
Release trials-2026-11-12-0.4.0
ClinicalTrials.gov's posted results, through CTTI's AACT: ClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299 ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
ClinicalTrials.gov: none stated ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
NIH RePORTER's clinical studies and project files: Public domain (NIH RePORTER)